Effect of Vitamin D3 in patients with Traumatic Brain Injury

Phase 3

• Conditions: Moderate to severe Traumatic brain injury.; Multiple injuries of head; S09.8

• Registration Number: IRCT20180522039777N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

TBI patients with age range of 18 to 65 years GCS score between 3 and 12 TBI patients with vitamin D level less than 30 ng/ml

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum level of Interleukin-1-beta. Timepoint: The first day of study entry and 72 hours later. Method of measurement: Patient serum sample.

Secondary Outcome Measures

Name	Time	Method
eutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR). Timepoint: From the first day of sampling for 7 consecutive days. Method of measurement: Blood cell count.